Repare Therapeutics Inc (RPTX) Event Aug. 04, 2022, 00:00 UTC (61% Neutral) Repare Therapeutics Inc. (RPTX) Reports Financial Results for 2022-06-30 Full text
Register to leave comments News bot Oct. 29, 2025, noon 🏢 Repare Therapeutics Inc (RPTX) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-08-04 📊 Period of Report: 2022-06-30 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Total Assets $368.71M $308.04M $60.67M +19.70% 📈 Total Liabilities $80.29M $82.53M $-2.23M -2.71% ↘️ Stockholders' Equity $225.52M $-283.12M $508.63M +179.66% 📈 Operating Income/Loss $-48.25M $-73.56M $25.32M +34.41% 📉 R&D Expense $36.71M $57.93M $-21.22M -36.63% 📈 Earningspersharebasic $-1.29 $-1.74 $0.45 +25.86% 📈 Earningspersharediluted $-1.29 $-1.74 $0.45 +25.86% 📈 📈 Financial Trend Analysis 🏦 Strengthened balance sheet with assets growing faster than liabilities 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 Repare Therapeutics Inc (RPTX) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
🏦 Strengthened balance sheet with assets growing faster than liabilities
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document